ANG logo

ANG Lifesciences India Ltd

ANG·BSE·
34.09 +0.66 (+1.97%)
Market Cap42.81 Cr
PE Ratio
Volume1,365
Day High - Low34.09 - 33.40
52W High-Low49.69 - 17.63
DocStoX Score
1.4/10
Poor
Fair Value
Sign in to see
ROE
-19.00%
Weak
P/E
Debt / Equity
1.49
Elevated
Industry
Healthcare
Pharmaceuticals
Overall View
Poor

Price performance

Day33.40
34.09
52W17.63
49.69
DocStoX take

Supported by valuation (6.0), but held back by growth (0.0).

DocStoX score

Low confidence
1.4
/10
Poor
Quality
Weak
ROE -19.0%
Valuation
Fair
P/B 0.7× on assets (no earnings to value)
Growth
Flat
Revenue -9.6% 5Y CAGR
Risk
High risk
D/E 1.49
Momentum
Firm
51% of 52-week range

At a glance

Market Cap
₹43 Cr
52W High / Low
₹50 / ₹18
Dividend Yield
3.41%
Promoter Holding
70.60%
EPS (TTM)
₹-9.50
Book Value
₹40.50

Key highlights

  • Revenue shrinking 10% a year
  • Loss-making in some of the last 5 years
0 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

ANG Lifesciences India Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.